[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2463 Introduced in House (IH)]
114th CONGRESS
1st Session
H. R. 2463
To authorize the Attorney General to provide grants for drug disposal
sites.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 20, 2015
Mr. Bera (for himself and Mr. Roe of Tennessee) introduced the
following bill; which was referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
A BILL
To authorize the Attorney General to provide grants for drug disposal
sites.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Dispose Responsibly of your Pills
Act of 2015'' or ``DROP Act of 2015''.
SEC. 2. GRANTS FOR DRUG DISPOSAL SITES.
(a) Program Authorized.--The Attorney General, in coordination with
the Administrator of the Drug Enforcement Administration, the Secretary
of Health and Human Services, and the Director of the Office of
National Drug Control Policy, may make grants to eligible entities to
expand or make available disposal sites for unwanted prescription
medications.
(b) Application.--
(1) In general.--An eligible entity desiring a grant under
this section shall submit an application to the Attorney
General--
(A) that meets the criteria under paragraph (2);
and
(B) at such time, in such manner, and accompanied
by such information as the Attorney General may
require.
(2) Criteria.--An eligible entity, in submitting an
application under paragraph (1), shall--
(A) describe the evidence-based methodology and
outcome measurements that will be used to evaluate the
program funded with a grant under this section, and
specifically explain how such measurements will provide
valid measures of the impact of the program;
(B) describe how the program could be broadly
replicated if demonstrated to be effective; and
(C) identify the governmental and community
agencies that will coordinate the program.
(c) Use of Funds.--An eligible entity shall use a grant received
under this section for--
(1) expenses of a prescription drug disposal site,
including materials and resources;
(2) implementing disposal procedures and processes;
(3) implementing community education strategies, including
community education materials and resources;
(4) replicating a prescription drug take back initiative
throughout multiple jurisdictions; and
(5) training of law enforcement officers and other
community participants.
(d) Grant Amounts and Duration.--
(1) Maximum amount.--The Attorney General may not award a
grant under this section in an amount that exceeds $250,000.
(2) Duration.--The Attorney General shall award grants
under this section for a period not to exceed 2 years.
(e) Technical Assistance Grant.--The Attorney General shall make a
grant to provide technical assistance and training for an eligible
entity receiving a grant under this section.
(f) Evaluation.--
(1) In general.--The Attorney General shall make a grant
for evaluation of the performance of each eligible entity
receiving a grant under this section.
(2) Reports.--Each fiscal year, the recipient of a grant
under this subsection shall submit to the Attorney General a
report that evaluates--
(A) the effectiveness of the prescription drug take
back program of each eligible entity receiving a grant
under this section; and
(B) the effect of disposal efforts on drug
circulation.
(3) Public availability.--The Attorney General shall make
the reports submitted under paragraph (2) publicly available on
the public Internet website of the Attorney General.
(g) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $2,500,000 for each of fiscal
years 2016 through 2020.
(h) Definition of Eligible Entity.--In this section, the term
``eligible entity'' means--
(1) a State, local, or tribal law enforcement agency;
(2) a manufacturer, distributor, or reverse distributor of
prescription medications;
(3) a retail pharmacy;
(4) a registered narcotic treatment program;
(5) a hospital or clinic with an on-site pharmacy;
(6) an eligible long-term care facility; or
(7) any other entity authorized by the Drug Enforcement
Administration to dispose of prescription medications.
<all>